CoChat

Introduction of SARS in France, March–April, 2003

Open access
Desenclos, Jean-Claude, van der Werf, Sylvie, Bonmarin, Isabelle, Levy-Bruhl, Daniel, Yazdanpanah, Yazdan, Hoen, Bruno, Emmanuelli, Julien, Lesens, Olivier, Dupon, Michel, Natali, François, Michelet, Christian, Reynes, Jacques, Guery, Benoit, Larsen, Christine, Semaille, Caroline, Mouton, Yves, Christmann, Daniel, André, Michel, Escriou, Nicolas, Burguière, Anna, Manuguerra, Jean-Claude, Coignard, Bruno, Lepoutre, Agnés, Meffre, Christine, Bitar, Dounia, Decludt, Bénédicte, Capek, Isabelle, Antona, Denise, Che, Didier, Herida, Magid, Infuso, Andréa, Saura, Christine, Brücker, Gilles, Hubert, Bruno, LeGoff, Dominique, Scheidegger, Suzanne · 2004 · Emerging Infectious Diseases
Cited by 53

The DOI matches its Crossref record.

Abstract

We describe severe acute respiratory syndrome (SARS) in France.Patients meeting the World Health Organization definition of a suspected case underwent a clinical, radiologic, and biologic assessment at the closest university-affiliated infectious disease ward.Suspected cases were immediately reported to the Institut de Veille Sanitaire.Probable case-patients were isolated, their contacts quarantined at home, and were followed for 10 days after exposure.Five probable cases occurred from March through April 2003; four were confirmed as SARS coronavirus by reverse transcription-polymerase chain reaction, serologic testing, or both.The index case-patient (patient A), who had worked in the French hospital of Hanoi, Vietnam, was the most probable source of transmission for the three other confirmed cases; two had been exposed to patient A while on the Hanoi-Paris flight of March 22-23.Timely detection, isolation of probable case-patients, and quarantine of their contacts appear to have been effective in preventing the secondary spread of SARS in France.S evere acute respiratory syndrome (SARS) was recent- ly identified as a new clinical entity (1).SARS likely originated in the Guangdong Province of People's Republic of China (2) and subsequently spread worldwide as infected persons traveled.During the 2003 outbreak, SARS was primarily transmitted by person-to-person contact between healthcare workers or household members and ill patients (2).Community transmission also occurred in several of the most affected areas, and an explosive outbreak from a common source occurred in Amoy Garden in Hong-Kong (3).As of June 2003, a total of 8,477 probable cases and 811 deaths had been reported from 32 countries (4).A novel coronavirus has been identified as the cause of SARS (5-7).Based on current knowledge, SARS is transmitted from symptomatic patients by close direct or indirect contacts through respiratory droplet secretions (2).In specific situations, other modes of transmission, such as airborne spread, may be possible (8).The incubation period ranges from 2 to 10 days, allowing SARS to spread over long distances by infected persons who travel (8,9).We describe how SARS was introduced in France through a single patient who returned from Vietnam on March 23 and present data that suggest transmission from this patient to other passengers may have occurred during his flight back from Hanoi to Paris. Materials and MethodsAfter the World Health Organization (WHO) alert on March 12, 2003, a centralized surveillance system was set up for SARS in France (10).All persons who returned from an area affected by recent transmission, had been in contact with a probable case during the previous 10 days, and in whom fever was >38°C, with cough or difficult breathing, were advised to call the emergency service.These persons were transported to the closest universityaffiliated infectious disease ward or one of the nine infectious disease wards designated as a regional reference center in the French plan of action against bioterrorism, using masks for droplet protection.After performing clinical and Introduction of SARS in France,

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid1002.030351

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 53

Metadata

Authors
Desenclos, J.-C., van der Werf, S., Bonmarin, I., Levy-Bruhl, D., Yazdanpanah, Y., Hoen, B., Emmanuelli, J., Lesens, O., Dupon, M., Natali, F., Michelet, C., Reynes, J., Guery, B., Larsen, C., Semaille, C., Mouton, Y., Christmann, D., André, M., Escriou, N., Burguière, A., Manuguerra, J.-C., Coignard, B., Lepoutre, A., Meffre, C., Bitar, D., Decludt, B., Capek, I., Antona, D., Che, D., Herida, M., Infuso, A., Saura, C., Brücker, G., Hubert, B., LeGoff, D., & Scheidegger, S.
Venue
Emerging Infectious Diseases
Published
2004-02
Volume
10
Issue
2
Pages
195-200
ISSN
  • 1080-6040 (ISSN-L)
  • 1080-6059
OpenAlex
W2050386855
Cited by
53
References
0
FWCI
3.39
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Introduction of SARS in France, March–April, 2003. https://app.cochat.ai/papers/10.3201/eid1002.030351
The paper
Desenclos, J.-C., van der Werf, S., Bonmarin, I., Levy-Bruhl, D., Yazdanpanah, Y., Hoen, B., Emmanuelli, J., Lesens, O., Dupon, M., Natali, F., Michelet, C., Reynes, J., Guery, B., Larsen, C., Semaille, C., Mouton, Y., Christmann, D., André, M., Escriou, N., . . . Scheidegger, S. (2004). Introduction of SARS in France, March–April, 2003. Emerging Infectious Diseases. https://doi.org/10.3201/eid1002.030351

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.